A detailed history of First Affirmative Financial Network transactions in Novo Nordisk A S stock. As of the latest transaction made, First Affirmative Financial Network holds 4,411 shares of NVO stock, worth $468,139. This represents 0.29% of its overall portfolio holdings.

Number of Shares
4,411
Previous 4,666 5.47%
Holding current value
$468,139
Previous $666,000 21.17%
% of portfolio
0.29%
Previous 0.47%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$119.07 - $145.42 $30,362 - $37,082
-255 Reduced 5.47%
4,411 $525,000
Q2 2024

Jul 10, 2024

SELL
$122.71 - $146.91 $28,591 - $34,230
-233 Reduced 4.76%
4,666 $666,000
Q1 2024

Apr 11, 2024

SELL
$102.11 - $135.92 $83,423 - $111,046
-817 Reduced 14.29%
4,899 $629,000
Q4 2023

Jan 08, 2024

SELL
$87.78 - $105.45 $100,947 - $121,267
-1,150 Reduced 16.75%
5,716 $591,000
Q3 2023

Oct 16, 2023

BUY
$90.94 - $199.54 $296,737 - $651,099
3,263 Added 90.56%
6,866 $624,000
Q2 2023

Jul 10, 2023

SELL
$155.98 - $172.65 $63,795 - $70,613
-409 Reduced 10.19%
3,603 $583,000
Q1 2023

Apr 11, 2023

SELL
$132.34 - $159.14 $45,127 - $54,266
-341 Reduced 7.83%
4,012 $638,000
Q4 2022

Jan 23, 2023

SELL
$102.55 - $135.33 $21,125 - $27,877
-206 Reduced 4.52%
4,353 $0
Q3 2022

Oct 20, 2022

SELL
$95.28 - $116.93 $43,066 - $52,852
-452 Reduced 9.02%
4,559 $454,000
Q2 2022

Jul 13, 2022

SELL
$103.24 - $121.81 $13,937 - $16,444
-135 Reduced 2.62%
5,011 $558,000
Q1 2022

Apr 12, 2022

BUY
$93.1 - $112.54 $37,705 - $45,578
405 Added 8.54%
5,146 $571,000
Q4 2021

Feb 15, 2022

BUY
$95.88 - $117.08 $23,298 - $28,450
243 Added 5.4%
4,741 $530,000
Q3 2021

Oct 26, 2021

BUY
$84.42 - $106.62 $379,721 - $479,576
4,498 New
4,498 $432,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track First Affirmative Financial Network Portfolio

Follow First Affirmative Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Affirmative Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on First Affirmative Financial Network with notifications on news.